BN Business News
Add your company to Business Communicator →

Regulation & law · 17/09/2007Updated: 10/17/2026 · 1 min read

Determination of Regulatory Review Period for Purposes of Patent Extension; Fel-O-Vax LvK/FIV Vaccine

Summary

The Animal and Plant Health Inspection Service has determined the regulatory review period for the Fel-O-Vax LvK/FIV Vaccine, a veterinary biologic, in response to a patent extension application submitted to the Commissioner of Patents and Trademarks. This determination is required by law and has been published as a notice.

Original source language: Federal Register — All DocumentsOpen original release →

Explore insights

Business insights →